XNAS: KYTX
Kyverna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made...
Read More
7.53
0.09
(1.21%)
543.2K
XNAS Volume
XNAS 17 Jul, 2026 2:12 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Kyverna Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..